Status:
COMPLETED
Evaluation of Patient Characteristics and Treatment Approaches to Patients With Bipolar Disorder in Turkey
Lead Sponsor:
AstraZeneca
Conditions:
Bipolar Disorder
Eligibility:
All Genders
18+ years
Brief Summary
A registry study to identify the patient-diagnosis-treatment characteristic profile of patients with bipolar disorder in Turkey.
Eligibility Criteria
Inclusion
- Patients previously or currently diagnosed with bipolar disorder
- Patients (or any of their relatives) who give a written informed consent.
Exclusion
- Patients who were previously included in this study.
Key Trial Info
Start Date :
March 1 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2009
Estimated Enrollment :
1018 Patients enrolled
Trial Details
Trial ID
NCT00660712
Start Date
March 1 2008
End Date
March 1 2009
Last Update
May 25 2009
Active Locations (19)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Adana, Turkey (Türkiye)
2
Research Site
Afyonkarahisar, Turkey (Türkiye)
3
Research Site
Ankara, Turkey (Türkiye)
4
Research Site
Antalya, Turkey (Türkiye)